Cardinal Health, Inc. (NYSE:CAH) Shares Bought by Mizuho Securities USA LLC

Mizuho Securities USA LLC grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 45.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 22,937 shares of the company’s stock after purchasing an additional 7,125 shares during the period. Mizuho Securities USA LLC’s holdings in Cardinal Health were worth $2,713,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Rothschild Investment LLC lifted its position in Cardinal Health by 10.1% in the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company’s stock valued at $101,000 after buying an additional 79 shares during the last quarter. Private Trust Co. NA lifted its holdings in shares of Cardinal Health by 11.0% in the 4th quarter. Private Trust Co. NA now owns 930 shares of the company’s stock worth $110,000 after acquiring an additional 92 shares during the last quarter. Checchi Capital Advisers LLC boosted its position in shares of Cardinal Health by 2.7% during the 4th quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company’s stock worth $411,000 after purchasing an additional 93 shares during the period. MWA Asset Management raised its position in Cardinal Health by 2.9% in the fourth quarter. MWA Asset Management now owns 3,324 shares of the company’s stock valued at $393,000 after purchasing an additional 95 shares during the period. Finally, Transcend Capital Advisors LLC raised its position in Cardinal Health by 3.6% in the fourth quarter. Transcend Capital Advisors LLC now owns 2,735 shares of the company’s stock valued at $323,000 after purchasing an additional 96 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

Shares of NYSE CAH opened at $133.25 on Tuesday. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $133.67. The company has a market capitalization of $32.19 billion, a price-to-earnings ratio of 24.86, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. The business has a 50-day moving average of $127.60 and a two-hundred day moving average of $120.24.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, equities research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.52%. Cardinal Health’s dividend payout ratio is currently 37.69%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Jefferies Financial Group raised Cardinal Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. Citigroup boosted their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research note on Friday, January 10th. Argus set a $148.00 price objective on shares of Cardinal Health in a report on Tuesday, February 4th. Evercore ISI raised shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price on the stock in a research note on Tuesday, January 7th. Finally, Bank of America raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $132.00 to $145.00 in a research report on Monday, January 6th. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.